Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Gross Profit (2016 - 2025)

Historic Gross Profit for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $207.0 million.

  • Integra Lifesciences Holdings' Gross Profit rose 337.25% to $207.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $859.8 million, marking a year-over-year increase of 4.01%. This contributed to the annual value of $882.1 million for FY2024, which is 30.22% down from last year.
  • Latest data reveals that Integra Lifesciences Holdings reported Gross Profit of $207.0 million as of Q3 2025, which was up 337.25% from $209.3 million recorded in Q2 2025.
  • Integra Lifesciences Holdings' Gross Profit's 5-year high stood at $250.1 million during Q4 2022, with a 5-year trough of $194.4 million in Q1 2025.
  • In the last 5 years, Integra Lifesciences Holdings' Gross Profit had a median value of $226.5 million in 2023 and averaged $225.9 million.
  • Its Gross Profit has fluctuated over the past 5 years, first soared by 5583.89% in 2021, then crashed by 1699.4% in 2023.
  • Quarter analysis of 5 years shows Integra Lifesciences Holdings' Gross Profit stood at $249.3 million in 2021, then increased by 0.33% to $250.1 million in 2022, then fell by 9.43% to $226.5 million in 2023, then increased by 9.97% to $249.1 million in 2024, then dropped by 16.9% to $207.0 million in 2025.
  • Its last three reported values are $207.0 million in Q3 2025, $209.3 million for Q2 2025, and $194.4 million during Q1 2025.